Stockreport

Agios Pharmaceuticals, Inc. (AGIO) Discusses FDA Approval of AQVESME for Anemia in Alpha and Beta Thalassemia Transcript [Seeking Alpha]

Agios Pharmaceuticals, Inc.  (AGIO) 
Last agios pharmaceuticals, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.agios.com/investor-overview
PDF Company Participants Morgan Sanford - Vice President of Investor Relations Brian Goff - CEO & Director Sarah Gheuens - Chief Medical Officer and Head of Research [Read more]